Evidence map›Paper›PMID 32403082›Full record

ArticleEBioMedicine2020

Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes' toxicity.

Che-Hong Chen, Julio C B Ferreira, Amit U Joshi, Matthew C Stevens, Sin-Jin Li, Jade H-M Hsu, Rory Maclean, Nikolas D Ferreira, Pilar R Cervantes, Diana D Martinez and 3 more

Expression of concernErratum issuedOpen access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Correlation BetweenCardiovascular therapeutics · 2026
    Article
  6. Review
  7. Carcinogenicity of vinyl acetate: evidence from multiple data streams.Environmental health : a global access science source · 2025
    Review
  8. Review
  9. ALDH2 Enzyme Deficiency in Diabetic Cardiomyopathy.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Role of Metabolism on Alcohol Preference, Addiction, and Treatment.Current topics in behavioral neurosciences · 2025
    Review
  12. Review
  13. HostFrontiers in microbiology · 2025
    Article
  14. Article
  15. Article
  16. Endogenous ethanol production in health and disease.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Che-Hong ChenDepartment of Chemical and Systems Biology, School of Medicine, Stanford University, CA, USA.
Julio C B FerreiraDepartment of Chemical and Systems Biology, School of Medicine, Stanford University, CA, USA; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Amit U JoshiDepartment of Chemical and Systems Biology, School of Medicine, Stanford University, CA, USA.
Matthew C StevensDepartment of Chemical and Systems Biology, School of Medicine, Stanford University, CA, USA.
Sin-Jin LiDepartment of Chemical and Systems Biology, School of Medicine, Stanford University, CA, USA; Department of Animal Science and Technology, National Taiwan University, Taipei, Taiwan.
Jade H-M HsuDepartment of Chemical and Systems Biology, School of Medicine, Stanford University, CA, USA; Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan.
Rory MacleanDepartment of Chemical and Systems Biology, School of Medicine, Stanford University, CA, USA.
Nikolas D FerreiraDepartment of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Pilar R CervantesTranslational Medicine and Innovation Unit, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México.
Diana D MartinezTranslational Medicine and Innovation Unit, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México.
Fernando L BarrientosTranslational Medicine and Innovation Unit, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México.
Gibran H R QuintanaresTranslational Medicine and Innovation Unit, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México.
Daria Mochly-RosenDepartment of Chemical and Systems Biology, School of Medicine, Stanford University, CA, USA. Electronic address: mochly@stanford.edu.
Stanford University · USInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXUniversidade de São Paulo · BRNational Taiwan University of Science and Technology · TWNational Yang Ming Chiao Tung University · TW

Funding

MECHANISMS OF ETHANOL-INDUCED CARDIAC PROTECTIONR01AA011147 · NIAAA · STANFORD UNIVERSITY · PI DARIA MOCHLY-ROSEN · 1996 to 2026
$8.2M
NIAAA NIH HHS R01 AA011147
6 · The paper itself

Abstract

backgroundAldehyde dehydrogenase 2 (ALDH2) catalyzes the detoxification of aliphatic aldehydes, including acetaldehyde. About 45% of Han Chinese (East Asians), accounting for 8% of humans, carry a single point mutation in ALDH2*2 (E504K) that leads to accumulation of toxic reactive aldehydes.

methodsSequencing of a small Mexican cohort and a search in the ExAC genomic database for additional ALDH2 variants common in various ethnic groups was set to identify missense variants. These were evaluated in vitro, and in cultured cells expressing these new and common variants.

findingsIn a cohort of Hispanic donors, we identified 2 novel mutations in ALDH2. Using the ExAC genomic database, we found these identified variants and at least three other ALDH2 variants with a single point mutation among Latino, African, South Asian, and Finnish ethnic groups, at a frequency of >5/1000. Although located in different parts of the ALDH2 molecule, these common ALDH2 mutants exhibited a significant reduction in activity compared with the wild type enzyme in vitro and in 3T3 cells overexpressing each of the variants, and a greater ethanol-induced toxicity. As Alda-1, previously identified activator, did not activate some of the new mutant ALDH2 enzymes, we continued the screen and identified Alda-64, which is effective in correcting the loss of activity in most of these new and common ALDH2 variants.

interpretationSince ~80% of the world population consumes ethanol and since acetaldehyde accumulation contributes to a variety of diseases, the identification of additional inactivating variants of ALDH2 in different ethnic groups may help develop new 'precision medicine' for carriers of these inactive ALDH2.

Indexed as

MutationAcetaldehydeAlcoholic IntoxicationAldehyde Dehydrogenase, MitochondrialAnimalsAsian PeopleBenzamidesBenzodioxolesBinding SitesBiotransformationBlack PeopleCloning, MolecularEscherichia coliEthanolGene ExpressionHispanic or LatinoAcetaldehydeAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanBenzamidesBenzodioxolesEthanolN-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamideRecombinant ProteinsAlcohol toxicityAlda-1 and -64ALDH2 deficiencyHealth burdenNovel mutations

Identifiers

PMID32403082
PMCPMC7218264
OpenAlexW3022566433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.